MAZZIOTTI, Gherardo
 Distribuzione geografica
Continente #
NA - Nord America 8.041
AS - Asia 5.107
EU - Europa 1.673
SA - Sud America 815
AF - Africa 248
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 3
Totale 15.900
Nazione #
US - Stati Uniti d'America 7.909
SG - Singapore 3.431
CN - Cina 740
BR - Brasile 644
VN - Vietnam 450
FI - Finlandia 327
IT - Italia 293
IE - Irlanda 231
DE - Germania 175
NG - Nigeria 169
FR - Francia 155
GB - Regno Unito 118
HK - Hong Kong 109
NL - Olanda 91
IN - India 79
AR - Argentina 73
CA - Canada 68
RU - Federazione Russa 49
BD - Bangladesh 48
SE - Svezia 39
MX - Messico 37
PL - Polonia 31
IQ - Iraq 28
JP - Giappone 27
ES - Italia 25
TR - Turchia 25
EC - Ecuador 24
PK - Pakistan 23
ZA - Sudafrica 23
CL - Cile 21
UA - Ucraina 21
BE - Belgio 20
ID - Indonesia 20
MK - Macedonia 20
PH - Filippine 19
VE - Venezuela 17
AT - Austria 15
CO - Colombia 14
SA - Arabia Saudita 13
IL - Israele 12
AU - Australia 11
TN - Tunisia 11
PY - Paraguay 10
CH - Svizzera 9
EG - Egitto 9
KE - Kenya 8
MA - Marocco 8
MY - Malesia 8
UZ - Uzbekistan 8
AE - Emirati Arabi Uniti 7
DZ - Algeria 7
JO - Giordania 7
KG - Kirghizistan 7
PA - Panama 7
CZ - Repubblica Ceca 6
GR - Grecia 6
IR - Iran 6
KR - Corea 6
LT - Lituania 6
AZ - Azerbaigian 5
CR - Costa Rica 5
DO - Repubblica Dominicana 5
OM - Oman 5
PE - Perù 5
RO - Romania 5
GE - Georgia 4
HR - Croazia 4
HU - Ungheria 4
TT - Trinidad e Tobago 4
UY - Uruguay 4
BO - Bolivia 3
ET - Etiopia 3
KZ - Kazakistan 3
LV - Lettonia 3
NO - Norvegia 3
NP - Nepal 3
PT - Portogallo 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
A2 - ???statistics.table.value.countryCode.A2??? 2
BG - Bulgaria 2
GT - Guatemala 2
HN - Honduras 2
JM - Giamaica 2
LB - Libano 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
TJ - Tagikistan 2
UG - Uganda 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AO - Angola 1
BH - Bahrain 1
BN - Brunei Darussalam 1
CG - Congo 1
CI - Costa d'Avorio 1
DK - Danimarca 1
EE - Estonia 1
GA - Gabon 1
Totale 15.890
Città #
Singapore 1.480
Chandler 1.202
Wilmington 1.097
Dallas 736
Ashburn 472
The Dalles 437
San Mateo 390
Shanghai 371
Helsinki 327
San Jose 313
Ann Arbor 262
Dublin 231
Boardman 208
New York 198
Lawrence 188
Princeton 188
Leawood 181
Beijing 179
Benin City 169
Ho Chi Minh City 152
Paris 123
Hanoi 112
Hong Kong 96
Fairfield 94
Milan 87
Woodbridge 81
Amsterdam 65
Los Angeles 58
Santa Clara 49
London 48
São Paulo 46
Seattle 43
Orem 29
San Diego 27
Montreal 25
Warsaw 24
Haiphong 23
Naples 21
Rio de Janeiro 21
Brussels 20
Brooklyn 19
Norwalk 19
Da Nang 18
Lahore 18
Toronto 18
Boston 17
Falkenstein 17
Frankfurt am Main 17
Assago 16
Council Bluffs 14
Johannesburg 14
Porto Alegre 14
Tokyo 14
Abbiategrasso 13
Belo Horizonte 13
Buenos Aires 13
Chicago 13
Manchester 13
Mumbai 13
Phoenix 13
Pune 13
Curitiba 12
Mexico City 12
Monmouth Junction 12
Quito 12
Redmond 12
Charlotte 11
Dhaka 11
Houston 11
Biên Hòa 10
Buffalo 10
Munich 10
Stockholm 10
Campinas 9
Hải Dương 9
Madrid 9
Rome 9
Salvador 9
San Francisco 9
Skopje 9
Brasília 8
Chennai 8
Reston 8
Ribeirão Preto 8
Tashkent 8
Ankara 7
Fortaleza 7
Shenzhen 7
Amman 6
Bishkek 6
City of London 6
Erbil 6
Riyadh 6
Sorocaba 6
Baghdad 5
Baku 5
Bauru 5
Bitola 5
Bogotá 5
Cairo 5
Totale 10.515
Nome #
CLINICAL PRESENTATION OF BONE METASTASES IN NEUROENDOCRINE TUMORS: A RETROSPECTIVE COHORT STUDY 372
Outcome of Sars-COV-2-related thyrotoxicosis in survivors of Covid-19: a prospective study 203
Procoagulant Imbalance in Klinefelter Syndrome Assessed by Thrombin Generation Assay and Whole-Blood Thromboelastometry 196
Safety of Romosozumab in women with cancer and osteoporosis at high risk of fractures 175
Genomewide Association Study of Severe Covid-19 with Respiratory Failure 128
Artificial intelligence-based radiomics on computed tomography of lumbar spine in subjects with fragility vertebral fractures 119
Acromegalic osteopathy 104
Advancing age and insulin resistance: role of plasma tumor necrosis factor-alpha 102
Biological activity of activating thyrotrophin receptor mutants: modulation by iodide 97
A Consensus on the Diagnosis and Treatment of Acromegaly Comorbidities: An Update. 97
Association between L-thyroxine treatment, GH deficiency, and radiological vertebral fractures in patients with adult-onset hypopituitarism 92
An improved polymerase chain reaction (PCR) protocol for unambiguous detection of growth hormone gene deletions 91
Biochemical Evaluation of Patients with Active Acromegaly and Type 2 Diabetes Mellitus: Efficacy and Safety of the Galanin Test 90
Abdominal Aortic Calcification as a Marker of Relationship Between Atherosclerosis and Skeletal Fragility 90
A Multicenter Cohort Study in Patients With Primary Empty Sella: Hormonal and Neuroradiological Features Over a Long Follow-Up 89
Pituitary Diseases and Bone 89
Active acromegaly enhances spontaneous parathyroid hormone pulsatility 89
Imbalance of the osteoprotegerin/RANKL ratio in bone marrow microenvironment after allogeneic hemopoietic stem cell transplantation 88
Possible delayed diagnosis and treatment of metastatic differentiated thyroid cancer by adopting the 2015 ATA guidelines 88
Autoimmune thyroiditis after elimination of iodine deficiency in Sri Lanka 88
Medullary thyroid carcinoma treated with percutaneous ultrasound-guided radiofrequency ablation 88
Alteration of the immunophenotype and cytokine profiles in patients affected by neuroendocrine neoplasms 85
Lack of association between changes in plasma leptin concentration and in food intake during the menstrual cycle 84
High Prevalence of Radiological Vertebral Fractures in Patients With TSH-Secreting Pituitary Adenoma (vol 2, pg 1089, 2018) 83
Pituitary Diseases and Bone 83
Body composition, trabecular bone score and vertebral fractures in subjects with Klinefelter syndrome 82
Case Report: New CDKN1B Mutation in Multiple Endocrine Neoplasia Type 4 and Brief Literature Review on Clinical Management 82
Bone and Joint Disorders in Acromegaly 79
Molecular imaging in acromegaly: should clinicians look carefully at developments in the field? 79
Tear thyrotropin receptor stimulator in normal smokers and thyroid eye disease patients 78
Occurrence of thyroid autoimmunity and dysfunction throughout a nine-month follow-up in patients undergoing interferon-beta therapy for multiple sclerosis 78
Serum and follicular fluid cytokines in polycystic ovary syndrome during stimulated cycles 77
Outcome of glucose homeostasis in patients with glucocorticoid-induced osteoporosis undergoing treatment with bone active-drugs 77
Temporal relationship between the appearance of thyroid autoantibodies and development of destructive thyroiditis in patients undergoing treatment with two different type-1 interferons for HCV-related chronic hepatitis: A prospective study 77
High Prevalence of Radiological Vertebral Fractures in Women on Thyroid-Stimulating Hormone-Suppressive Therapy for Thyroid Carcinoma 77
The addition of ribavirin to interferon-alpha therapy in patients with hepatitis C virus-related chronic hepatitis does not modify the thyroid autoantibody pattern but increases the risk of developing hypothyroidism 77
GH receptor isoforms and skeletal fragility in acromegaly 77
Effects of pegvisomant and somatostatin receptor ligands on incidence of vertebral fractures in patients with acromegaly 77
Growth hormone, insulin-like growth factors, and the skeleton 76
Postintervention serum TSH levels may be useful to differentiate patients who should undergo levothyroxine suppressive therapy after thyroid surgery for multinodular goiter in a region with moderate iodine deficiency 76
Impact of chronic exposure to 5-alpha reductase inhibitors on the risk of hospitalization for COVID-19: a case-control study in male population from two COVID-19 regional centers of Lombardy, Italy 76
Morbidity and mortality of bone metastases in advanced adrenocortical carcinoma: a multicenter retrospective study 75
Bone turnover, bone mineral density, and fracture risk in acromegaly: a meta-analysis 74
Type-1 response in peripheral CD4(+) and CD8(+) T cells from patients with Hashimoto's thyroiditis 74
Insulin and GH-IGF-I axis: endocrine pacer or endocrine disruptor? 74
New understanding and treatments for osteoporosis 74
Bone disorders associated with acromegaly: mechanisms and treatment 74
High bone marrow fat in patients with Cushing's syndrome and vertebral fractures. 73
Multimodal conservative treatment of migrating bone marrow edema associated with early osteonecrosis of the hip 73
A practical use of bone turnover markers in management of patients with skeletal fragility 72
Primary hyperparathyroidism in prostate cancer: guilty or not guilty? 72
Glucocorticoid-induced osteoporosis: Clinical and therapeutic aspects 72
Resistance to somatostatin analogs in acromegaly: An evolving concept? 72
Bone safety of dual-release hydrocortisone in patients with hypopituitarism 72
Effects of increased thyroxine dosage pre-conception on thyroid function during early pregnancy 72
Thyrotoxicosis in patients with COVID-19: the THYRCOV study 72
Low testosterone predicts hypoxemic respiratory insufficiency and mortality in patients with COVID-19 disease: another piece in the COVID puzzle 72
Medullary thyroid cancer, papillary thyroid microcarcinoma and Graves' disease: An unusual clinical coexistence 71
Investigational drugs targeting somatostatin receptors for treatment of acromegaly and neuroendocrine tumors 71
High-resolution-cone beam tomography analysis of bone microarchitecture in patients with acromegaly and radiological vertebral fractures 71
Current and Emerging Aspects of Diabetes Mellitus in Acromegaly 71
Increased serum reverse triiodothyronine levels at diagnosis of hepatocellular carcinoma in patients with compensated HCV-related liver cirrhosis 71
Somatostatin analogs in the treatment of neuroendocrine tumors: current and emerging aspects 70
The hypertension of Cushing's syndrome: controversies in the pathophysiology and focus on cardiovascular complications. 70
HMG-CoA reductase inhibitors inhibit rat propylthiouracil-induced goiter by modulating the ras-MAPK pathway 70
Recombinant growth hormone (GH) therapy in GH-deficient adults: A long-term controlled study on daily versus thrice weekly injections 70
COVID-19 vaccines and blood glucose control: Friend or foe? 69
Parathyroid hormone pulsatility: physiological and clinical aspects 69
Impaired growth hormone secretion associated with low glucocorticoid levels: an experimental model for the Giustina effect 69
Diagnosis and treatment of acromegaly and its complications: consensus guidelines. 69
CT-based radiomics can identify physiological modifications of bone structure related to subjects' age and sex 68
Reevaluating thyrotropin receptor-induced mouse models of Graves' disease and ophthalmopathy 68
Treatment of hypothyroidism: all that glitters is gold? 68
Prevalence of Vertebral Fractures in Men with Acromegaly 68
Evolution of thyroid autoimmunity during iodine prophylaxis - the Sri Lankan experience 68
High prevalence of radiological vertebral fractures in adult patients with Ehlers-Danlos syndrome 68
Cardiovascular risk in aging and obesity: Is there a role for GH? 68
High prevalence of radiological vertebral fractures in women with prolactin-secreting pituitary adenomas 68
Serum insulin-like growth factor I evaluation as a useful tool for predicting the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis - A prospective study 68
High-Dose and High-Frequency Lanreotide Autogel in Acromegaly: A Randomized, Multicenter Study 68
In memoriam: Dr. Irene Claudia Floriani (1964-2016) 68
Vitamin D deficiency, secondary hyperparathyroidism and respiratory insufficiency in hospitalized patients with COVID-19 68
Eight parathyroid glands incidentally discovered during a surgical intervention for secondary hyperparathyroidism: An unusual clinical finding 67
Parity as a thyroid size-determining factor in areas with moderate iodine deficiency 67
Glucocorticoid replacement therapy and vertebral fractures in hypopituitary adult males with GH deficiency 67
Meta-Analysis on the Effects of Octreotide on Tumor Mass in Acromegaly 67
Morphometric vertebral fractures in patients with castration-resistant prostate cancer undergoing treatment with radium-223: a longitudinal study in the real-life clinical practice. 67
Real-life management and outcome of thyroid carcinoma-related bone metastases: results from a nationwide multicenter experience 67
Iodized salt improves the effectiveness of L-thyroxine therapy after surgery for nontoxic goitre: a prospective and randomized study 67
Long-term outcome of interferon-alpha-induced thyroid autoimmunity and prognostic influence of thyroid autoantibody pattern at the end of treatment 67
Diabetic Ketoacidosis: Considerations and Residual Controversies in Management After the 2024 ADA, EASD, JBDS, AACE, and DST Joint Consensus 66
Is chronic autoimmune thyroiditis a systemic disease? 66
Growth hormone replacement therapy and fracture risk 66
Diabetes insipidus and increased serum levels of leptin and lactate-dehydrogenase (LDH) in an adolescent boy with a primary intracranial germinoma. Case Report and an endocrinological revaluation of literature 66
Growth hormone deficiency in the adult 66
Influence of diabetes mellitus on vertebral fractures in men with acromegaly 66
Long-term effects of lanreotide SR and octreotide LAR (R) on tumour shrinkage and GH hypersecretion in patients with previously untreated acromegaly 66
Assessment of DXA derived bone quality indexes and bone geometry parameters in early breast cancer patients: A single center cross-sectional study 66
Could low prolactin levels after radiotherapy predict the onset of hypopituitarism? 65
Acromegalic osteopathy: An update 65
Totale 8.243
Categoria #
all - tutte 104.616
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 104.616


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021420 0 0 0 0 0 0 0 0 0 228 3 189
2021/2022911 75 6 8 222 0 4 16 141 83 102 179 75
2022/20233.027 410 127 267 339 312 291 13 263 508 256 194 47
2023/20241.662 130 199 314 96 47 188 88 95 46 28 160 271
2024/20252.635 72 32 49 45 27 245 141 268 438 596 350 372
2025/20265.999 952 329 766 668 220 241 1.780 394 346 303 0 0
Totale 16.104